德源药业
(920735)
| 流通市值：25.76亿 | | | 总市值：29.13亿 |
| 流通股本：1.14亿 | | | 总股本：1.29亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 853,684,890.27 | 597,402,013.06 | 294,181,481.42 | 1,057,759,831.41 |
| 营业总成本 | 634,392,412.07 | 439,712,417.99 | 229,701,547.23 | 800,394,506.98 |
| 其他经营收益 | | | | |
| 营业利润 | 226,017,829.47 | 161,606,184.83 | 66,046,362.96 | 268,244,588.13 |
| 利润总额 | 229,396,248.28 | 161,661,117.72 | 66,090,536.22 | 266,581,965.12 |
| 净利润 | 186,652,645.92 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 186,652,645.92 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,029,036,946.06 | 980,864,446.47 | 935,331,322.76 | 859,484,472.08 |
| 非流动资产: | | | | |
| 非流动资产合计 | 755,308,711.7 | 729,731,095.03 | 718,070,932.38 | 711,609,191.36 |
| 资产总计 | 1,784,345,657.76 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 |
| 流动负债: | | | | |
| 流动负债合计 | 261,281,424.76 | 244,426,006.12 | 259,278,122.43 | 192,269,197.3 |
| 非流动负债: | | | | |
| 非流动负债合计 | 76,447,205.08 | 77,545,929.43 | 78,646,248.31 | 71,933,688.14 |
| 负债合计 | 337,728,629.84 | 321,971,935.55 | 337,924,370.74 | 264,202,885.44 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,446,617,027.92 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 |
| 股东权益合计 | 1,446,617,027.92 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 |
| 负债和股东权益合计 | 1,784,345,657.76 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 846,214,188.64 | 567,934,756.5 | 285,544,901.38 | 1,098,035,941.41 |
| 经营活动现金流出小计 | 731,424,266.14 | 500,788,077.65 | 250,717,867.58 | 941,368,857.52 |
| 经营活动产生的现金流量净额 | 114,789,922.5 | 67,146,678.85 | 34,827,033.8 | 156,667,083.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 886,522,657.51 | 664,999,751.88 | 281,442,878.73 | 1,866,375,267.98 |
| 投资活动现金流出小计 | 895,086,424.22 | 664,459,779.23 | 277,823,804.85 | 2,174,345,684.51 |
| 投资活动产生的现金流量净额 | -8,563,766.71 | 539,972.65 | 3,619,073.88 | -307,970,416.53 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 7,968,561.82 | 4,252,388.38 | 245,000 | 8,790,000 |
| 筹资活动现金流出小计 | 48,513,152.36 | 47,664,396.2 | 646,155.08 | 64,370,318.79 |
| 筹资活动产生的现金流量净额 | -40,544,590.54 | -43,412,007.82 | -401,155.08 | -55,580,318.79 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 65,681,565.25 | 24,274,643.68 | 38,044,952.6 | -206,883,651.43 |
| 期末现金及现金等价物余额 | 162,776,518.11 | 121,369,596.54 | 135,139,905.46 | 97,094,952.86 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 24,274,643.68 | - | -206,883,651.43 |